Marc Engelsgjerd, Vice President of Search and Evaluation at Royalty Pharma, shared a post on LinkedIn:
“It was an honor to moderate a fireside chat with cell therapy pioneer Carl June at the Alliance for Cancer Gene Therapy luncheon last week during the Society for Immunotherapy of Cancer (SITC) annual meeting.
A great conversation on the current state of cell therapy for cancer, emerging technical innovation, and strategies for navigating policy, funding, and access challenges.”
More posts about SITC25.